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Genetic variation in CACNA1C, which encodes the alpha-1 
subunit of Cav1.2 L-type voltage-gated calcium channels 
(VGCCs), has been strongly linked to risk for psychiat-
ric disorders including schizophrenia and bipolar disorder. 
How genetic variation in CACNA1C contributes to risk for 
these disorders is however not fully known. Both schizo-
phrenia and bipolar disorder are associated with impair-
ments in reversal learning (RL), which may contribute to 
symptoms seen in these conditions. We used a translational 
RL paradigm to investigate whether genetic variation in 
CACNA1C affects RL in both humans and transgenic rats. 
Associated changes in gene expression were explored using 
in situ hybridization and quantitative PCR in rats and 
the BRAINEAC online human database. Risk-associated 
genetic variation in CACNA1C in healthy human partici-
pants was associated with impairments in RL. Consistent 
with this finding, rats bearing a heterozygous deletion of 
Cacna1c were impaired in an analogous touchscreen RL 
task. We investigated the possible molecular mechanism 
underlying this impairment and found that Cacna1c +/− 
rats show decreased expression of Bdnf in prefrontal cor-
tex. Examination of BRAINEAC data showed that human 
risk-associated genetic variation in CACNA1C is also 
associated with altered expression of brain-derived neuro-
trophic factor (BDNF) in the prefrontal cortex in humans. 
These results indicate that genetic variation in CACNA1C 
may contribute to risk for schizophrenia and bipolar disor-
der by impacting behavioral flexibility, potentially through 
altered regulation of BDNF expression in the prefrontal 
cortex. Tests of RL may be useful for translational studies 
and in the development of therapies targeting VGCCs.
Key words:  reversal learning/rat/behavior/BDNF/transl
ational/calcium
Introduction
Genetic variation in CACNA1C, which encodes the 
alpha-1 subunit of Cav1.2 L-type voltage-gated calcium 
channels (VGCCs), has been strongly linked to risk for 
psychiatric disorders including schizophrenia and bipolar 
disorder.1,2 The association between common genetic var-
iation in intron 3 of the CACNA1C gene and schizophre-
nia and bipolar disorder has been confirmed by multiple 
studies across different populations.1,3–7 Risk mediated 
through common variants in CACNA1C has also been 
found to be shared across disorders, with Smoller et al2 
finding similar associations with attention deficit hyper-
activity disorder (ADHD), autism spectrum disorder, 
bipolar disorder, major depressive disorder, and schizo-
phrenia. Expression studies in cell lines and postmortem 
tissue have suggested that the intron 3 risk variants may 
act to decrease expression of CACNA1C, although the 
exact direction of effect has varied between studies and 
tissue types.8–12 Rare deleterious mutations in VGCCs 
have also been found to be associated with risk for schiz-
ophrenia.13 Notably, this enrichment was primarily driven 
by pore-forming alpha-1 subunits and alpha-2-delta aux-
iliary subunits of VGCCs, including deleterious mutation 
loss of function variants in CACNA1C.13
The robust association of CACNA1C with multi-
ple psychiatric disorders has led to the investigation of 
potential endophenotypes and downstream biological 
mechanisms that may link genetic risk to disease-relevant 
behavior. Previous studies have identified a link between 
risk-associated variation in CACNA1C and a range 
of tasks requiring cognitive and behavioral flexibility. 
Specifically, genetic variation in CACNA1C and related 
VGCCs has been strongly associated with working mem-
ory performance as assessed by the N-back test, which is 
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known to depend on prefrontal cortex (PFC) function.14–16 
Genetic variation in CACNA1C has similarly been shown 
to affect logical memory in patients17 and verbal work-
ing memory in healthy controls.18 CACNA1C genotype 
has also been found to affect reward learning.19,20 Genetic 
imaging studies have been conducted to identify neural 
circuits affected by genetic variation in CACNA1C and 
have shown altered activation of fronto-limbic brain cir-
cuitry in risk allele carriers.12,15,19,21
Reversal learning (RL) tasks represent a powerful 
method for investigating cognitive flexibility with con-
siderable potential for cross-species translational stud-
ies.22 RL involves the inhibition of  a previously learnt 
association between a stimulus and reward and the 
acquisition of  a new opposite contingency or rule. It 
is a necessary form of  behavioral flexibility that allows 
new experience to influence behavior.23 Deficits in this 
form of  learning can lead to inappropriate persevera-
tive behavior that is not supported by, or beneficial in, 
the current environment. Impairments in RL have been 
reliably observed in patients with a range of  psychiat-
ric conditions including schizophrenia and bipolar dis-
order.24–29 Furthermore, deficits in RL have also been 
observed in first-episode psychosis patients30 and in the 
context of  high polygenic risk for schizophrenia,31 sug-
gesting that RL deficits may reflect a causal mechanism 
linking common genetic schizophrenia risk to symp-
tomology. Homologous fronto-limbic networks have 
been found to be involved in RL in both rodents and 
humans,22,23,32 and the development of  a touchscreen-
based RL paradigm for rodents makes the task highly 
translatable.33,34
At a molecular level, the neurotrophin brain-derived 
neurotrophic factor (BDNF) has been shown to play 
a critical role in PFC during RL.35,36 Mice lacking the 
main activity-regulated form of  Bdnf show impaired 
plasticity in the PFC and behavioral deficits in RL 
tasks.35,36 Furthermore, manipulations in animal mod-
els that decrease prefrontal Bdnf, including maternal 
separation, have been shown to result in impairments 
in RL.37,38 VGCCs, including CACNA1C, have been 
shown to be central to the activity-dependent regula-
tion of  BDNF, suggesting the possibility that genetic 
variation in CACNA1C may affect cognitive flexibil-
ity in part through altering Bdnf expression in the 
PFC.39–43
On the basis of these findings, we sought to investigate 
the effect on RL of CACNA1C risk variants in humans 
and altered Cacna1c dosage in rats. We additionally 
assessed the impact of genetic variation in CACNA1C 
on prefrontal BDNF levels in both humans and rats. 
By conducting these behavioral, genetic, and molecular 
studies in parallel, we aimed to increase confidence in our 
findings and develop translational models for the future 
development of novel therapies for psychiatric disorders 
targeting VGCCs.
Methods and Materials
Human Participants
One hundred right-handed Caucasian healthy partici-
pants (aged 19–47  years) derived from the local com-
munity took part in the study. Ethical approval was given 
by the ethics committee of the School of Psychology, 
Cardiff  University, and informed consent was obtained 
from each participant prior to the study. Participants had 
no history of psychiatric illness (themselves or first-de-
gree relative) and did not report taking any psychotro-
pic medication or illegal substances. All participants were 
right-handed, university graduates (with 17+ years’ edu-
cation). A total of 84 participants (mean age 23.95 ± 3.64 
SD, 49 women) were used for analysis, after exclusion for 
quality control of genetic data (N = 10) or incomplete/
missing behavioral data (N  =  6). The data used in this 
study have previously been used to observe associations 
between genome-wide polygenic risk for schizophrenia 
and RL behavior.31
Probabilistic RL Behavioral Task
Participants were asked to make a choice between a blue 
and a green stimulus presented simultaneously (figure 1). 
A correct response was followed by a white “smiley” face 
Fig. 1. Reversal learning paradigm. Participants were presented 
with a choice between blue or green squares. Correct choices were 
rewarded with monetary winning and incorrect responses with 
a fine. One or two probabilistic error trials were included within 
each session block in which the “correct” response was punished.
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and rewarded with a +1 p monetary reward and a red 
“frowny” face and a −1 p monetary punishment followed 
an incorrect response. Participants were told to max-
imize their “earnings” throughout the task. After 7–11 
trials, the contingencies were reversed and the previously 
rewarded stimulus was now punished. In total there were 
12 reversal sessions (total of 108 choice trials). Each ses-
sion included 1 or 2 “probabilistic errors” in which the 
correct response was punished to ensure sufficient diffi-
culty in the task. “Total Earnings” were calculated for 
each participant for the full task (in pence) based on 
the amount of rewards and punishments they received 
throughout. Performance following the first contingency 
reversal (“Reversal Accuracy”) was calculated as percent-
age correct for that session block.
DNA Extraction and Participant Genotyping
Samples of saliva were collected from participants for 
genotyping using Oragene DNA (OG-500) kits (DNA 
Genotek Inc). Genotyping was conducted using a cus-
tom HumanCoreExome BeadChip Kit (Illumina), which 
included 570 038 variants. Data were quality-controlled 
in PLINK.44 Participants were removed if  data suggested 
non-European ancestry, relation to other participants, 
or incomplete genotyping <97%. Genotypes were then 
imputed by estimating haplotypes using SHAPEIT and 
imputing genotypes from the reference set 1000 genomes 
(December 2013, release 1000 genomes haplotypes 
phase 1 integrated variant set) using IMPUTE245,46. For 
the current analysis, genotypes were extracted from the 
full single-nucleotide polymorphism (SNP) dataset for 
rs1006737 and rs2007044 only. These SNPs were selected 
because rs1006737 is the most consistently reported dis-
ease-associated SNP in CACNA1C across disorders,47 
and the most recent schizophrenia genome-wide associa-
tion study found rs2007044 to have the strongest associa-
tion with schizophrenia (as well as confirming association 
with rs1006737).48 These 2 SNPs are in high linkage dis-
equilibrium (r2  =  .8). Allelic association analyses were 
conducted to determine whether incidence of each indi-
vidual allele at each SNP location was associated with 
performance. Student’s t tests were used to compare per-
formance for each allele.
Animals
Eighty-eight male Sprague-Dawley Cacna1c hetero-
zygous (HET) knockout rats were housed with wild-
type (WT) littermates in groups of 1–4. Heterozygous 
Cacna1c Sprague–Dawley rats were obtained from cryo-
preserved embryos, created with zinc-finger nuclease 
(ZFN) technology (Sage Research Labs). A pair of 5-fin-
ger ZFNs, recognizing a total of 30 base pairs, was used 
to target exon 6 (location 460649–460652 bp in genomic 
sequence), resulting in a frameshift and an early stop 
codon. Manipulation of founders was confirmed by PCR 
(Fwd: 5′- GCTGCTGAGCCTTTTATTGG-3′; Rev: 5′- 
CCTCCTGGATAGCTGCTGAC-3′) and sequencing. 
Details of basic molecular and behavioral characteriza-
tion of Cacna1c HET rats are given in the Supplementary 
Material, including supplementary figure S1. Given the 
limitations of individual Cav1.2 alpha-1 subunit antibod-
ies, we used 2 separate antibodies in western blots and 
an ELISA assay to confirm protein levels are reduced in 
our heterozygous line (see Supplementary Material). All 
procedures were conducted in accordance with the guide-
lines published in the Institute of Laboratory Animals 
Resources Commission on Life Sciences 1996 Guide for 
the Care and Use of Laboratory Animals.
Animal Touchscreen RL Paradigm
In this study, 13 WT and 12 HET rats were tested using 
a touchscreen RL task.33 Animals were placed on water 
restriction on testing days to maximize motivation for 
reward, in accordance with Home Office regulations. 
Animals were run in sets of 4 using Bussey–Saksida 
rat touchscreen chambers (model 80604; Campden 
Instruments) with accompanying Animal Behavior 
Environment Test (ABET) II software (model 89505; 
Campden Instruments). The overall stages and criteria 
for moving on to the next phase of the experiment are 
shown in supplementary table  S1. Animals were pre-
trained to collect the reward (10% sucrose solution) from 
the magazine (Habituation), and to nose poke a stimu-
lus to receive reward (Must Touch). Following comple-
tion of pretraining, animals were presented with a pair 
of stimuli (S+ and S−, side of presentation was allocated 
pseudorandomly). Touches to the S+ resulted in delivery 
of the reward and the termination of the trial. Touches to 
the S− resulted in the termination of the trial and a 10 s 
time-out period before the next trial could be initiated 
(figure 2). Visual discrimination training continued until 
an animal was performing at 80% correct within a session 
on 2 consecutive days (supplementary table S1), follow-
ing this the contingencies were reversed (S+ becomes the 
S−, and vice versa). Early phase reversal was character-
ized by overcoming the previously learnt association and 
obtaining at least 50% correct responding to the newly 
rewarded stimulus. Late phase reversal was defined as 
obtaining 80% correct responding to the newly rewarded 
stimulus on 2 consecutive days (supplementary table S1).
Correct responses and number of errors (incorrect 
responses) for each session were recorded to establish 
performance across phases and perseveration. For each 
session of discrimination and RL, % correct response 
[(correct responses/total responses) ×  100] was calcu-
lated. The number of sessions and trials required to reach 
criterion were recorded for each condition. Animals were 
only included if  they had reached criterion for that train-
ing phase. The proportion of animals of each genotype 
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to complete each phase was compared to establish suc-
cess rate. Latencies to respond to stimuli were recorded to 
indicate speed of decision and response. Latencies were 
averaged across the first 3 sessions and the last 3 sessions 
to give an indication of change within phase. Student’s t 
tests were used to compare the number of sessions taken 
to complete and error number per session and chi-squared 
tests were used to compare the frequency of completion 
for experimental condition by genotype. Repeated meas-
ures ANOVAs with time and genotype were conducted to 
analyze response latencies across sessions.
Quantitative In Situ Hybridization
In situ hybridization was used to quantify the expression 
of Bdnf and Cacna1c in rodent tissue using established 
techniques.49,50 Full details of the in situ hybridization 
methods and analysis are given in the Supplementary 
Material.
Quantitative PCR
Quantitative PCR (qPCR) was conducted with SensiMix 
SYBR Green (Bioline) as described in Supplementary 
Material.
Human Gene Expression Analysis by Risk SNP
We examined the effects of genetic variation in 
CACNA1C at rs1006737 and rs2007044 on postmortem 
gene expression using the BRAINEAC online database 
(www.braineac.org).51 Using the BRAINEAC online gen-
eral user interface, the expression of BDNF was stratified 
by rs1006737 and rs2007044 for each individual probe 
set available. Allele frequencies for the two SNPS were 
rs1006737: A = 29.1%, G = 70.9%; rs2007044: G = 36.9%, 
A = 63.1%.
Results
Healthy Human CACNA1C Risk Allele Carriers Show 
Altered RL
The risk allele at both rs1006737 and rs2007044 was asso-
ciated with fewer correct responses during RL (figure 3). 
Average performance associated with the risk allele (A) 
at rs1006737 was 64.08% (SEM = 2.66%) compared with 
71.27% (SEM = 1.90) associated with the non-risk allele 
(G); and at rs2007044 average performance associated 
with the risk allele (G) was 64.66% (SEM = 2.41) com-
pared with 71.69% for the non-risk allele (SEM = 2.04%). 
Student’s t tests between revealed a significant effect of 
risk allele at rs1006737 and rs2007044 with first “Reversal 
Accuracy” [t(166) = −2.242, P = .026 and t(165) = −2.230, 
P = .027, respectively]. There were no significant effects 
of risk allele at rs1006737 (t(166)  =  −1.562, P  =  .120) 
or rs2007044 on “Total Earnings” [t(165)  =  −1.122, 
P =  .264] indicating comparative levels of task motiva-
tion. Further analysis confirmed that the association 
between CACNA1C risk allele and performance was spe-
cific to trials following reversal and was not affected by 
correction for relevant covariates including age and gen-
der (see Supplementary Material including supplemen-
tary figure S2 and supplementary table S3).
Cacna1c Heterozygote Rats Show Altered RL
There were no differences between rat genotypes in num-
ber of sessions to reach criteria for Habituation or Must 
Touch [t(21) = −0.249, P =  .806 and t(18.206) = 1.323, 
P = .202, respectively]. Twelve of the 13 WT animals and 
9 out of 12 HETs animals reached criteria for “Visual 
Discrimination” with no difference in the proportion of 
completion [χ(1)  =  1.391, P  =  .238] or number of ses-
sions taken to reach criteria [t(19) = −0.833, P =  .415]. 
Fig. 2. Schematic of trials used for Visual Discrimination and Reversal sessions for correct and incorrect responses. Inter trial interval 
(ITI).
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Analyses were conducted to compare the proportion of 
WT and HET animals that completed the “Early” rever-
sal stage, indicating a successful inhibition of response 
to prior contingency. Fewer HETs completed “Early 
Reversal,” with 12 WT animals successfully complet-
ing early reversal (92%), compared with 7 HET animals 
(58%) [χ(1) = 3.949, P = .047] (figure 4). Mean number 
of sessions for the completion of each training session 
by HET and WT animals are shown in supplementary 
table S4. This pattern was reflected in the total number 
of errors made at each stage. Specifically, there was no 
difference between genotypes in total errors during the 
Visual Discrimination phase [t(21) = −0.001, P = 1], but 
HET animals made significantly more errors compared 
to WT during Early Reversal [t(17) = 2.176, P = .044].
Comparison of response latencies further indicates 
altered behavior in HET animals following reversal of 
contingencies. There was no evidence of a difference in 
time to respond to stimuli during Visual Discrimination 
[F(1,19)  =  1.134, P  =  .300]; however, HET animals 
responded significantly faster than WT during early 
reversal [F(1,16)  =  10.921, P  =  .004] (supplementary 
figure S3).
Reduced Prefrontal Cortex Bdnf Expression in 
Cacna1c Heterozygote Rats
qPCR analysis revealed a significant decrease in the 
expression of Bdnf in the PFC of Cacna1c heterozygous 
rats [t(19) = −2.223, P = .039] (figure 5), with no differ-
ences observed in the CA1 region of the hippocampus 
[t(19) = 0.741, P = .408]. In situ hybridization was used to 
further compare levels of Bdnf mRNA expression in the 
PFC of a separate cohort of Cacna1c HET (n = 5) and 
WT (n = 5) rats. Analysis confirmed that HET animals 
showed significantly reduced expression of total Bdnf 
mRNA levels in the PFC compared with WT animals 
[t(8) = 2.316, P =  .049] (figure 5), with no difference in 
expression in the hippocampal CA1 field [t(8) = −1.418, 
P = .194].
Risk SNPs in CACNA1C are associated with decreased 
expression of BDNF in human frontal cortex
We investigated whether genetic variation at the 
two CACNA1C risk loci is associated with expression 
changes of  BDNF in the human PFC. Examination of 
the BRAINEAC database revealed a significant asso-
ciation between genotype at rs1006737 and rs2007044 
and the expression of  BDNF (P  =  .007 and  =  .042, 
respectively) as assessed by probe set 3367273 (supple-
mentary figure S4). Risk allele carriers at both SNPs 
showed significantly reduced expression of  BDNF, 
with homozygous carriers having a more pronounced 
reduction.
Fig. 3. Comparison of accuracy following first reversal for risk 
and non-risk alleles at rs1006737 and rs2007044. Risk allele was 
associated with significantly reduced performance compared to 
non-risk allele carriers. Bars represent average % correct. Error 
bars are standard error of the mean (SEM). *P < .05.
Fig. 4. Completion rates (% of animals of each genotype) for 
each experimental condition from Must Touch to Reversal 
Criterion. Fewer HET animals compared to WT completed Early 
Reversal stage of 50% performance levels following reversal. *P < 
.05. WT = wild type.
Fig. 5. BDNF mRNA expression levels compared between 
WT and HET animals in PFC. Results show a 22% and a 
26% reduction in PFC in HET animals with ISH and qPCR 
respectively. Bars represent mean expression normalized to WT. 
*P < .05. BDNF = brain-derived neurotrophic factor; ISH = in 
situ hybridization; PFC = prefrontal cortex; qPCR = quantitative 
PCR; WT = wild type.
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Discussion
Summary
We report that healthy human subjects bearing alleles 
in the CACNA1C gene associated with risk for psychi-
atric disorders show poorer reversal performance on a 
probabilistic RL task than non-risk allele carriers. We 
also report convergent evidence that rats heterozygous 
for the Cacna1c gene are impaired in the same phase of 
RL. We show that Cacna1c hemizygosity in rats is associ-
ated with decreased Bdnf expression in the PFC, and that 
human risk variants in CACNA1C are also associated 
with decreased BDNF expression as indexed by selective 
markers in postmortem tissue. Overall, these results sug-
gest that genetic variation in CACNA1C may contribute 
to risk for psychiatric disorders through impacting cogni-
tive flexibility, and that at a molecular level, this may be in 
part caused by alterations in BDNF expression.
Human Risk Alleles in CACNA1C Impact RL
We found that risk-associated common genetic variants 
in CACNA1C were found to be associated with deficits in 
the reversal stage of a probabilistic RL task. Specifically, 
in healthy human participants the risk-associated alleles 
of CACNA1C were associated with impaired perfor-
mance in a probabilistic RL task, indicating an impact 
of genetic variation in CACNA1C on cognitive flexibil-
ity. These results suggest that the risk variant may be 
affecting neural circuitry involved in the comparison 
and updating of existing information to inform subse-
quent behavior and forming optimal choice contingen-
cies. Prior studies in human participants suggest a specific 
role for the PFC, especially orbito-frontal regions, and 
the striatum in RL.22 Furthermore, human genetic imag-
ing studies have indicated an impact of genetic variation 
of CACNA1C genotype on fronto-limbic brain activa-
tion and connectivity, although the impact of CACNA1C 
genotype on brain activation during RL has not been 
specifically investigated.12,15,21,52 Polygenic risk scores for 
schizophrenia, to which genetic variants in CACNA1C 
contribute, have however been shown to influence fronto-
striatal brain activation during RL.31
Cognitive flexibility is known to be impaired in a range 
of psychiatric disorders that have been associated with 
genetic variation in CACNA1C. Deficits in RL have, for 
example, been demonstrated in patients with psychotic 
disorders including schizophrenia and bipolar disor-
der.23,25–27,29,30 In schizophrenia, impairments in RL have 
been shown to be related to clinical ratings of symptoms 
including disorganization and thought disorder, findings 
that were not explained by impairments in general intel-
ligence.26 Furthermore, imaging studies of patients with 
schizophrenia performing RL tasks have demonstrated 
altered activation of fronto-striatal brain networks.29,53 
The present results suggest that genetic variation in the 
psychiatric risk gene CACNA1C may contribute to the 
impairments in cognitive flexibility seen in these disorders.
Alterations in Cacna1c in Rats Impact RL
In a touchscreen reward-based RL task, we found that 
Cacna1c heterozygous knockout rats demonstrated a 
selective impairment in the early stage of RL. Specifically, 
fewer Cacna1c heterozygous animals successfully reached 
criteria for reversal. Furthermore, heterozygous animals 
responded more quickly and with more errors, indicative 
of behavioral inflexibility and inappropriate responding. 
This pattern of responses is consistent with a lack of inhi-
bition of previous responding. There was no difference 
between Cacna1c heterozygous animals and controls 
during the initial visual discrimination component of 
the task, indicating that these animals could successfully 
acquire novel stimulus–reward associations. These results 
therefore suggest that Cacna1c heterozygous animals 
have a selective impairment in inhibition and the switch-
ing of reinforced contingencies.
These results in rats show a striking degree of conver-
gence with the effects seen on RL in human risk allele 
carriers, suggesting that the low-dosage Cacna1c rat may 
represent a valuable model of the effects of genetic var-
iation in CACNA1C on cognition in humans. It is nota-
ble that some, although not all, reports of the effects 
of CACNA1C genotype on expression suggest that the 
common variants in humans may be associated with 
decreased CACNA1C expression.9,10 Furthermore delete-
rious mutations in L-type VGCCs have also been asso-
ciated with risk for schizophrenia in exome-sequencing 
studies, further implicating low dosage of L-type VGCCs 
in risk for this disorder.13
Our results are broadly consistent with previous stud-
ies on mice with forebrain-specific total knockout of 
Cacna1c.54,55 Koppe et al55 found forebrain-specific con-
ditional Cacna1c knockout mice adopt different behav-
ioral strategies during an operant reward-based learning 
task compared to controls. Cacna1c knockout mice did 
not show an overall behavioral deficit; however, detailed 
behavioral analysis showed that these animals gained 
reward based on an outcome-based strategy, rather than 
learning cue–reward associations, basing their responses 
more on the previous location of the reward.55 Similarly, 
Temme et al54 found that mice lacking forebrain Cacna1c 
could learn contextual and spatial associations normally 
but were impaired on more subtle tests of context dis-
crimination and pattern completion. A recent study also 
demonstrated impacts of Cacna1c hemizygosity on social 
behavior and communication.56 Our results extend these 
previous findings to show an impact of genetic manip-
ulation of Cacna1c on behavioral flexibility as assessed 
by RL. In addition, we show a significant behavioral 
effect of reduced dosage, rather than total ablation, of 
Cacna1c. This is important as genetic variants associated 
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with increased risk for psychiatric disorders in humans 
are anticipated to affect Cacna1c dosage and not to pro-
duce a total ablation of the gene (which is not compatible 
with viability).9,10,13
Impact of Genetic Variation in CACNA1C on 
Prefrontal BDNF Across Species
L-type VGCCs are known to play a critical role in the 
regulation of BDNF expression.39,57 Previous studies in 
mice completely lacking forebrain Cacna1c have also 
demonstrated a reduction in central BDNF levels.58 
Furthermore, activity-dependent regulation of BDNF 
has been shown in rodent models to be critical for both 
plasticity in the PFC and RL.35,36 These findings suggest 
that altered regulation of BDNF in the PFC may contrib-
ute to deficits in RL.
We found that Cacna1c heterozygous rats have decreased 
expression of Bdnf in the PFC, a result we confirmed with 
both qPCR and in situ hybridization. These findings dem-
onstrate that decreased dosage of Cacna1c is sufficient to 
have a significant impact on prefrontal Bdnf expression. In 
addition, we found that CACNA1C risk-associated genetic 
variation in humans is associated with decreased BDNF 
expression in human PFC, as assessed by selected mark-
ers of BDNF in postmortem tissue in the BRAINEAC 
database. Notably, this effect was not seen for all markers 
across the BDNF gene, suggesting that genetic variation 
in CACNA1C may affect specific BDNF transcripts in the 
PFC, an area that will be important for future investiga-
tion. These results suggest a mechanism through which 
genetic variation in CACNA1C may affect cognitive flex-
ibility and RL, because previous studies have shown that 
mice lacking activity-regulated expression of Bdnf show 
impaired RL and altered spike-timing-dependent plastic-
ity in the PFC.35,36 These results also suggest that thera-
peutic approaches aimed at enhancing prefrontal BDNF 
levels may be efficacious in alleviating some of the cogni-
tive impairments seen in neuropsychiatric disorders.
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Supplementary material is available at Schizophrenia 
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